A range exists, but the evidence is preliminary
The range above is what studies or protocols have used, but no human trial has established that Retinalamin is effective at it. Converting a dose does not make the dose validated. See the graded evidence on the Retinalamin profile before relying on any figure here.
Convert your Retinalamin dose
Vial
Result
Converted amount5,000 mcg
Dose mass5,000 mcg
Concentration2,500 mcg/mL
Draw volume2 mL
U-100 syringe200 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| retinal degeneration research | intramuscular | 5–10 mg | daily for 10 days |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 5,000 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 2.5 mL | 250 units | 0 |
| 2 mg | 2 mL | 5 mL | 500 units | 0 |
| 2 mg | 3 mL | 7.5 mL | 750 units | 0 |
| 5 mg | 1 mL | 1 mL | 100 units | 1 |
| 5 mg | 2 mL | 2 mL | 200 units | 1 |
| 5 mg | 3 mL | 3 mL | 300 units | 1 |
| 10 mg | 1 mL | 0.5 mL | 50 units | 2 |
| 10 mg | 2 mL | 1 mL | 100 units | 2 |
| 10 mg | 3 mL | 1.5 mL | 150 units | 2 |
Calculated for the low end of the reported retinal degeneration research range. Change the dose in the calculator above for any other amount.
Retinalamin at a glance
Unknown (polypeptide complex — not characterized pharmacokinetically in Western literature)
Half-life
Not established
Molecular weight — molar conversion unavailable
intramuscular
Routes
research only
Legal status